Membranoproliferative glomerulonephritis (MPGN) type 2 is characterized by electron-dense deposits in the glomerular basement membrane and drusen-like deposits in Bruch's membrane. Over time, atrophic changes in the retina and retinal pigment epithelium occur, which can progress to choroidal neovascularization (CNV). This report describes a patient with MPGN type 2 who developed progressive loss of vision secondary to CNV. High-speed ultrahigh-resolution optical coherence tomography (UHR-OCT) showed an irregular Bruch's membrane that measured 10 μm beneath the foveal center. High-speed UHR-OCT can potentially be used to analyze Bruch's membrane in secondary ocular manifestations of diseases such as MPGN type 2 and primary retinal diseases such as age-related macular degeneration.
INTRODUCTION
Membranoproliferative glomerulonephritis type 2 is a complex genetic disease that typically presents in children between the ages of 5 and 15 years and leads to end-stage renal disease. 1 Ocular manifestations of membranoproliferative glomerulonephritis (MPGN) type 2 include drusen-like deposits in Bruch's membrane. 2 The composition of these deposits is similar to that of drusen in age-related macular degeneration (AMD), consistent with the current understanding that both share a complement-mediated pathogenesis. 3 Over time, atrophic changes in the retina and retinal pigment epithelium (RPE) become manifest and can eventually progress to choroidal neovascularization (CNV). 1 This report describes a patient with end-stage renal disease due to MPGN type 2 who presented with CNV in his left eye. High-speed ultrahigh-resolution optical coherence tomography (UHR-OCT) findings are described.
CASE REPORT
A 29-year-old man was referred to the New England Eye Center at Tufts Medical Center in Boston in 1999 for further management of a submacular CNV in his right eye. He had been treated previously with focal laser. He had a history of hypertension and end-stage renal disease requiring hemodialysis due to MPGN type 2 that was confirmed on renal biopsy. Of note, he was allergic to sodium fluorescein.
On initial evaluation, his right eye had a best corrected visual acuity (BCVA) of 20/40 without active CNV. His left eye had a BCVA of 20/20 and RPE mottling or drusen-like deposits in the macula without evidence of CNV. Over the ensuing 18 months, he developed recurrent CNV in the right eye that was unresponsive to focal laser, photodynamic therapy, and intravitreal corticosteroid injections. His BCVA eventually deteriorated to no light perception in the right eye after massive subretinal hemorrhage. The left eye remained stable on regular yearly follow-up examination for 12 years. 
DISCUSSION
This report describes a patient with end-stage renal disease due to MPGN type 2 who developed CNV, first in his right eye leading to complete loss of vision, and then many years later in his left eye that was successfully treated with intravitreal bevacizumab. Previous reports of patients with MPGN type 2 have reported retinal thinning and drusenlike RPE elevation using SD-OCT. 4 Novel high-speed UHR-OCT imaging in this patient suggests an irregular and prominent Bruch's membrane measuring 9 to 13 μm at three locations.
Analysis of alterations in Bruch's membrane is an emerging area of interest due to such changes being associated with disease states such as AMD. On histology, Bruch's membrane in the macular region of healthy eyes varies in thickness from 2 to 4.7 μm. 6 Currently available commercial SD-OCT systems and the new swept-source OCT technology offer an axial resolution of 5 to 7 μm in tissue and are therefore usually unable to delineate Bruch's membrane independent from the RPE in healthy eyes. In patients with detachment of RPE, Bruch's membrane is seen as a hyper-reflective line just below the level of the RPE. 7 In the present case, a prototype high-speed UHR-OCT with an axial resolution of approximately 3 μm in tissue showed an irregular and prominent Bruch's membrane (Figure 2, page 615) , a finding consistent with previous histopathological analysis in patients with MPGN type 2. 2 The measurements of the Bruch's membrane on high-speed UHR-OCT were comparable to those obtained on the commercially available SD-OCT, although the two OCT images were not consecutive in the present case.
Quantification of the thickness of Bruch's membrane using OCT is not a validated method owing to the limited resolution of the OCT systems currently in commercial and research use. As OCT technology advances, systems with high axial resolutions closer, if not comparable, to histology 8 may be helpful in detecting subtle early changes in diseases that exhibit a histologically proven thickening of Bruch's membrane such as AMD 9 and MPGN type 2. 2 In MPGN type 2 such as in this case, only invasive renal biopsy can predict the changes in glomerular basement membrane. An in vivo assessment using OCT in these patients could possibly predict the progression of renal disease with the caveat that an accurate assessment may be limited by the inherent resolution of the OCT system.
In conclusion, the present report is unique for two reasons. First, it describes a case of CNV secondary to MPGN type 2 imaged with a high-resolution OCT system. Second, the OCT images revealed an irregular and prominent Bruch's membrane consistent with the known histopathologic changes in this disease. It is expected that the improved axial resolution achieved by high-speed UHR-OCT may be able to reveal subtle Bruch's membrane changes in diseases such as MPGN type 2 and AMD. High-speed ultrahigh-resolution OCT image of the left eye shows detachment of the retinal pigment epithelium and an irregular and prominent Bruch's membrane seen as a hyperreflective line just below the level of the retinal pigment epithelium (white arrow) measuring 10 μm beneath the fovea, 9 μm at 1 mm temporal to the fovea, and 13 μm at 1 mm nasal to the fovea. Scale bar = 300 μm. Higher magnification of the OCT image shows a detached retinal pigment epithelium (RPE) and a prominent Bruch's membrane (white arrow) seen as a hyperreflective line just below the level of RPE that measured 9 μm beneath the fovea, 8 μm at 1 mm temporal to the fovea, and 12 μm at 1 mm nasal to the fovea using the linear measurement tool available on the spectral-domain OCT system. The retinal pigment epithelium (black arrow) is detached from Bruch's membrane. Scale bar = 10 μm.
